Cash & equivalents increased 23.4%
Cash & equivalents changed +23.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +23.4% from the comparable as-filed period.
Net income changed +143.8% from the comparable as-filed period.
Operating income changed +62.8% from the comparable as-filed period.
Operating margin changed +421 basis points from the comparable as-filed period.
Debt changed +18.1% from the comparable as-filed period.
Gross margin changed -130 basis points from the comparable as-filed period.
Revenue changed +5.3% from the comparable as-filed period.
Gross profit changed +3.6% from the comparable as-filed period.
Research & development changed +1.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.